Meanwhile, we have demonstrated miR-330 could promote cellular proliferation, migration and invasion of glioma U87 and U251 cells and glioma stem cells by targeting SH3GL2 (Qu et al., 2012; Yao et al., 2014). This evidence concerns the gene SH3GL2 and central nervous system cancer.